The Patient Perspective-Valuable for Drug Development

Congress, the Food and Drug Administration (FDA), drug developers, researchers and patient groups have all recognized the contribution patients and caregivers can make to the drug development process. Since 2012, the FDA has incorporated the patient’s voice in disease-specific “patient-focused drug development” (PFDD) meetings to help inform the regulatory drug approval process. Who better to tell the story of how a disease manifests, or what they are experiencing on a daily ba